microRNA	B:C2716184
-145	I:C2716184
Mediates	O
the	O
Inhibitory	O
Effect	O
of	O
Adipose	O
Tissue	I:C0001527
-	O
Derived	O
Stromal	O
Cells	I:C0162597
on	O
Prostate	O
Cancer	I:C0600139
.	O

microRNA	O
-145	I:C2716184
Mediates	O
the	O
Inhibitory	O
Effect	O
of	O
Adipose	B:C0001527
Tissue	I:C0001527
-	O
Derived	O
Stromal	O
Cells	I:C0162597
on	O
Prostate	O
Cancer	I:C0600139
.	O

microRNA	O
-145	I:C2716184
Mediates	O
the	O
Inhibitory	O
Effect	O
of	O
Adipose	O
Tissue	I:C0001527
-	O
Derived	O
Stromal	B:C0162597
Cells	I:C0162597
on	O
Prostate	O
Cancer	I:C0600139
.	O

microRNA	O
-145	I:C2716184
Mediates	O
the	O
Inhibitory	O
Effect	O
of	O
Adipose	O
Tissue	I:C0001527
-	O
Derived	O
Stromal	O
Cells	I:C0162597
on	O
Prostate	B:C0600139
Cancer	I:C0600139
.	O

Adipose	B:C0162597
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
(	I:C0162597
ASC	I:C0162597
)	I:C0162597
,	O
known	O
as	O
one	O
of	O
the	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	I:C1257975
MSCs	I:C1257975
)	I:C1257975
,	O
is	O
a	O
promising	O
tool	O
for	O
regenerative	O
medicine	I:C1257974
;	O
however	O
,	O
the	O
effect	O
of	O
ASCs	O
on	O
tumor	O
growth	O
has	O
not	O
been	O
studied	O
sufficiently	O
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
(	I:C0162597
ASC	I:C0162597
)	I:C0162597
,	O
known	O
as	O
one	O
of	O
the	O
mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
(	I:C1257975
MSCs	I:C1257975
)	I:C1257975
,	O
is	O
a	O
promising	O
tool	O
for	O
regenerative	O
medicine	I:C1257974
;	O
however	O
,	O
the	O
effect	O
of	O
ASCs	O
on	O
tumor	O
growth	O
has	O
not	O
been	O
studied	O
sufficiently	O
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
(	I:C0162597
ASC	I:C0162597
)	I:C0162597
,	O
known	O
as	O
one	O
of	O
the	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	I:C1257975
MSCs	I:C1257975
)	I:C1257975
,	O
is	O
a	O
promising	O
tool	O
for	O
regenerative	B:C1257974
medicine	I:C1257974
;	O
however	O
,	O
the	O
effect	O
of	O
ASCs	O
on	O
tumor	O
growth	O
has	O
not	O
been	O
studied	O
sufficiently	O
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
(	I:C0162597
ASC	I:C0162597
)	I:C0162597
,	O
known	O
as	O
one	O
of	O
the	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	I:C1257975
MSCs	I:C1257975
)	I:C1257975
,	O
is	O
a	O
promising	O
tool	O
for	O
regenerative	O
medicine	I:C1257974
;	O
however	O
,	O
the	O
effect	O
of	O
ASCs	B:C0162597
on	O
tumor	O
growth	O
has	O
not	O
been	O
studied	O
sufficiently	O
.	O

We	O
investigated	O
the	O
hypothesis	O
that	O
ASCs	B:C0162597
have	O
an	O
inhibitory	O
effect	O
on	O
metastatic	O
tumor	I:C0178874
progression	I:C0178874
.	O

We	O
investigated	O
the	O
hypothesis	O
that	O
ASCs	O
have	O
an	O
inhibitory	O
effect	O
on	O
metastatic	B:C0178874
tumor	I:C0178874
progression	I:C0178874
.	O

To	O
evaluate	O
the	O
in	O
vitro	O
inhibitory	O
effect	O
of	O
ASCs	B:C0162597
on	O
metastatic	O
prostate	I:C0936223
cancer	I:C0936223
(	I:C0936223
PCa	I:C0936223
)	I:C0936223
,	O
direct	O
coculture	O
and	O
indirect	O
separate	O
culture	O
experiments	I:C0430400
with	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
and	O
human	O
ASCs	O
were	O
performed	O
,	O
and	O
ASCs	O
were	O
administered	O
to	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cell	I:C0682523
-	O
derived	O
tumor	O
-	O
bearing	O
nude	O
mice	I:C0025932
for	O
in	O
vivo	I:C1515655
experiment	O
.	O

To	O
evaluate	O
the	O
in	O
vitro	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
metastatic	B:C0936223
prostate	I:C0936223
cancer	I:C0936223
(	I:C0936223
PCa	I:C0936223
)	I:C0936223
,	O
direct	O
coculture	O
and	O
indirect	O
separate	O
culture	O
experiments	I:C0430400
with	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
and	O
human	O
ASCs	O
were	O
performed	O
,	O
and	O
ASCs	O
were	O
administered	O
to	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cell	I:C0682523
-	O
derived	O
tumor	O
-	O
bearing	O
nude	O
mice	I:C0025932
for	O
in	O
vivo	I:C1515655
experiment	O
.	O

To	O
evaluate	O
the	O
in	O
vitro	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
metastatic	O
prostate	I:C0936223
cancer	I:C0936223
(	I:C0936223
PCa	I:C0936223
)	I:C0936223
,	O
direct	O
coculture	B:C0282547
and	O
indirect	O
separate	O
culture	O
experiments	I:C0430400
with	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
and	O
human	O
ASCs	O
were	O
performed	O
,	O
and	O
ASCs	O
were	O
administered	O
to	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cell	I:C0682523
-	O
derived	O
tumor	O
-	O
bearing	O
nude	O
mice	I:C0025932
for	O
in	O
vivo	I:C1515655
experiment	O
.	O

To	O
evaluate	O
the	O
in	O
vitro	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
metastatic	O
prostate	I:C0936223
cancer	I:C0936223
(	I:C0936223
PCa	I:C0936223
)	I:C0936223
,	O
direct	O
coculture	O
and	O
indirect	O
separate	O
culture	B:C0430400
experiments	I:C0430400
with	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
and	O
human	O
ASCs	O
were	O
performed	O
,	O
and	O
ASCs	O
were	O
administered	O
to	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cell	I:C0682523
-	O
derived	O
tumor	O
-	O
bearing	O
nude	O
mice	I:C0025932
for	O
in	O
vivo	I:C1515655
experiment	O
.	O

To	O
evaluate	O
the	O
in	O
vitro	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
metastatic	O
prostate	I:C0936223
cancer	I:C0936223
(	I:C0936223
PCa	I:C0936223
)	I:C0936223
,	O
direct	O
coculture	O
and	O
indirect	O
separate	O
culture	O
experiments	I:C0430400
with	O
PC3M	B:C0682523
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
and	O
human	O
ASCs	O
were	O
performed	O
,	O
and	O
ASCs	O
were	O
administered	O
to	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cell	I:C0682523
-	O
derived	O
tumor	O
-	O
bearing	O
nude	O
mice	I:C0025932
for	O
in	O
vivo	I:C1515655
experiment	O
.	O

To	O
evaluate	O
the	O
in	O
vitro	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
metastatic	O
prostate	I:C0936223
cancer	I:C0936223
(	I:C0936223
PCa	I:C0936223
)	I:C0936223
,	O
direct	O
coculture	O
and	O
indirect	O
separate	O
culture	O
experiments	I:C0430400
with	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
and	O
human	B:C0086418
ASCs	O
were	O
performed	O
,	O
and	O
ASCs	O
were	O
administered	O
to	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cell	I:C0682523
-	O
derived	O
tumor	O
-	O
bearing	O
nude	O
mice	I:C0025932
for	O
in	O
vivo	I:C1515655
experiment	O
.	O

To	O
evaluate	O
the	O
in	O
vitro	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
metastatic	O
prostate	I:C0936223
cancer	I:C0936223
(	I:C0936223
PCa	I:C0936223
)	I:C0936223
,	O
direct	O
coculture	O
and	O
indirect	O
separate	O
culture	O
experiments	I:C0430400
with	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
and	O
human	O
ASCs	B:C0162597
were	O
performed	O
,	O
and	O
ASCs	O
were	O
administered	O
to	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cell	I:C0682523
-	O
derived	O
tumor	O
-	O
bearing	O
nude	O
mice	I:C0025932
for	O
in	O
vivo	I:C1515655
experiment	O
.	O

To	O
evaluate	O
the	O
in	O
vitro	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
metastatic	O
prostate	I:C0936223
cancer	I:C0936223
(	I:C0936223
PCa	I:C0936223
)	I:C0936223
,	O
direct	O
coculture	O
and	O
indirect	O
separate	O
culture	O
experiments	I:C0430400
with	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
and	O
human	O
ASCs	O
were	O
performed	O
,	O
and	O
ASCs	B:C0162597
were	O
administered	O
to	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cell	I:C0682523
-	O
derived	O
tumor	O
-	O
bearing	O
nude	O
mice	I:C0025932
for	O
in	O
vivo	I:C1515655
experiment	O
.	O

To	O
evaluate	O
the	O
in	O
vitro	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
metastatic	O
prostate	I:C0936223
cancer	I:C0936223
(	I:C0936223
PCa	I:C0936223
)	I:C0936223
,	O
direct	O
coculture	O
and	O
indirect	O
separate	O
culture	O
experiments	I:C0430400
with	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
and	O
human	O
ASCs	O
were	O
performed	O
,	O
and	O
ASCs	O
were	O
administered	O
to	O
PC3	B:C0682523
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cell	I:C0682523
-	O
derived	O
tumor	O
-	O
bearing	O
nude	O
mice	I:C0025932
for	O
in	O
vivo	I:C1515655
experiment	O
.	O

To	O
evaluate	O
the	O
in	O
vitro	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
metastatic	O
prostate	I:C0936223
cancer	I:C0936223
(	I:C0936223
PCa	I:C0936223
)	I:C0936223
,	O
direct	O
coculture	O
and	O
indirect	O
separate	O
culture	O
experiments	I:C0430400
with	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
and	O
human	O
ASCs	O
were	O
performed	O
,	O
and	O
ASCs	O
were	O
administered	O
to	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cell	I:C0682523
-	O
derived	O
tumor	B:C3273930
-	O
bearing	O
nude	O
mice	I:C0025932
for	O
in	O
vivo	I:C1515655
experiment	O
.	O

To	O
evaluate	O
the	O
in	O
vitro	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
metastatic	O
prostate	I:C0936223
cancer	I:C0936223
(	I:C0936223
PCa	I:C0936223
)	I:C0936223
,	O
direct	O
coculture	O
and	O
indirect	O
separate	O
culture	O
experiments	I:C0430400
with	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
and	O
human	O
ASCs	O
were	O
performed	O
,	O
and	O
ASCs	O
were	O
administered	O
to	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cell	I:C0682523
-	O
derived	O
tumor	O
-	O
bearing	O
nude	B:C0025932
mice	I:C0025932
for	O
in	O
vivo	I:C1515655
experiment	O
.	O

To	O
evaluate	O
the	O
in	O
vitro	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
metastatic	O
prostate	I:C0936223
cancer	I:C0936223
(	I:C0936223
PCa	I:C0936223
)	I:C0936223
,	O
direct	O
coculture	O
and	O
indirect	O
separate	O
culture	O
experiments	I:C0430400
with	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
and	O
human	O
ASCs	O
were	O
performed	O
,	O
and	O
ASCs	O
were	O
administered	O
to	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cell	I:C0682523
-	O
derived	O
tumor	O
-	O
bearing	O
nude	O
mice	I:C0025932
for	O
in	B:C1515655
vivo	I:C1515655
experiment	O
.	O

To	O
evaluate	O
the	O
in	O
vitro	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
metastatic	O
prostate	I:C0936223
cancer	I:C0936223
(	I:C0936223
PCa	I:C0936223
)	I:C0936223
,	O
direct	O
coculture	O
and	O
indirect	O
separate	O
culture	O
experiments	I:C0430400
with	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
and	O
human	O
ASCs	O
were	O
performed	O
,	O
and	O
ASCs	O
were	O
administered	O
to	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cell	I:C0682523
-	O
derived	O
tumor	O
-	O
bearing	O
nude	O
mice	I:C0025932
for	O
in	O
vivo	I:C1515655
experiment	B:C0681814
.	O

We	O
also	O
performed	O
exosome	B:C2350332
microRNA	O
(	I:C1101610
miRNA	I:C1101610
)	I:C1101610
array	O
analysis	I:C1449653
to	O
explore	O
a	O
mechanistic	O
insight	O
into	O
the	O
effect	O
of	O
ASCs	O
on	O
PCa	O
cell	I:C0597032
proliferation	O
/	O
apoptosis	O
.	O

We	O
also	O
performed	O
exosome	O
microRNA	B:C1101610
(	I:C1101610
miRNA	I:C1101610
)	I:C1101610
array	O
analysis	I:C1449653
to	O
explore	O
a	O
mechanistic	O
insight	O
into	O
the	O
effect	O
of	O
ASCs	O
on	O
PCa	O
cell	I:C0597032
proliferation	O
/	O
apoptosis	O
.	O

We	O
also	O
performed	O
exosome	O
microRNA	O
(	I:C1101610
miRNA	I:C1101610
)	I:C1101610
array	B:C1449653
analysis	I:C1449653
to	O
explore	O
a	O
mechanistic	O
insight	O
into	O
the	O
effect	O
of	O
ASCs	O
on	O
PCa	O
cell	I:C0597032
proliferation	O
/	O
apoptosis	O
.	O

We	O
also	O
performed	O
exosome	O
microRNA	O
(	I:C1101610
miRNA	I:C1101610
)	I:C1101610
array	O
analysis	I:C1449653
to	O
explore	O
a	O
mechanistic	O
insight	O
into	O
the	O
effect	O
of	O
ASCs	B:C0162597
on	O
PCa	O
cell	I:C0597032
proliferation	O
/	O
apoptosis	O
.	O

We	O
also	O
performed	O
exosome	O
microRNA	O
(	I:C1101610
miRNA	I:C1101610
)	I:C1101610
array	O
analysis	I:C1449653
to	O
explore	O
a	O
mechanistic	O
insight	O
into	O
the	O
effect	O
of	O
ASCs	O
on	O
PCa	B:C0597032
cell	I:C0597032
proliferation	O
/	O
apoptosis	O
.	O

We	O
also	O
performed	O
exosome	O
microRNA	O
(	I:C1101610
miRNA	I:C1101610
)	I:C1101610
array	O
analysis	I:C1449653
to	O
explore	O
a	O
mechanistic	O
insight	O
into	O
the	O
effect	O
of	O
ASCs	O
on	O
PCa	O
cell	I:C0597032
proliferation	B:C0596290
/	O
apoptosis	O
.	O

We	O
also	O
performed	O
exosome	O
microRNA	O
(	I:C1101610
miRNA	I:C1101610
)	I:C1101610
array	O
analysis	I:C1449653
to	O
explore	O
a	O
mechanistic	O
insight	O
into	O
the	O
effect	O
of	O
ASCs	O
on	O
PCa	O
cell	I:C0597032
proliferation	O
/	O
apoptosis	B:C0162638
.	O

Both	O
in	O
vitro	O
and	O
in	B:C1515655
vivo	I:C1515655
experiments	O
exhibited	O
the	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cell	O
proliferation	I:C0596290
,	O
inducing	O
apoptosis	O
and	O
prostate	O
cancer	I:C0936223
growth	O
,	O
respectively	O
.	O

Both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
experiments	B:C0681814
exhibited	O
the	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cell	O
proliferation	I:C0596290
,	O
inducing	O
apoptosis	O
and	O
prostate	O
cancer	I:C0936223
growth	O
,	O
respectively	O
.	O

Both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
experiments	O
exhibited	O
the	O
inhibitory	O
effect	O
of	O
ASCs	B:C0162597
on	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cell	O
proliferation	I:C0596290
,	O
inducing	O
apoptosis	O
and	O
prostate	O
cancer	I:C0936223
growth	O
,	O
respectively	O
.	O

Both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
experiments	O
exhibited	O
the	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
PC3M	B:C0682523
-	I:C0682523
luc2	I:C0682523
cell	O
proliferation	I:C0596290
,	O
inducing	O
apoptosis	O
and	O
prostate	O
cancer	I:C0936223
growth	O
,	O
respectively	O
.	O

Both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
experiments	O
exhibited	O
the	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cell	B:C0596290
proliferation	I:C0596290
,	O
inducing	O
apoptosis	O
and	O
prostate	O
cancer	I:C0936223
growth	O
,	O
respectively	O
.	O

Both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
experiments	O
exhibited	O
the	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cell	O
proliferation	I:C0596290
,	O
inducing	O
apoptosis	B:C0162638
and	O
prostate	O
cancer	I:C0936223
growth	O
,	O
respectively	O
.	O

Both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
experiments	O
exhibited	O
the	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cell	O
proliferation	I:C0596290
,	O
inducing	O
apoptosis	O
and	O
prostate	B:C0936223
cancer	I:C0936223
growth	O
,	O
respectively	O
.	O

Both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
experiments	O
exhibited	O
the	O
inhibitory	O
effect	O
of	O
ASCs	O
on	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cell	O
proliferation	I:C0596290
,	O
inducing	O
apoptosis	O
and	O
prostate	O
cancer	I:C0936223
growth	B:C1516170
,	O
respectively	O
.	O

Among	O
upregulated	B:C0041904
miRNAs	O
in	O
ASCs	O
compared	O
with	O
fibroblasts	O
,	O
we	O
focused	O
on	O
miR	O
-145	I:C1537799
,	O
which	O
was	O
known	O
as	O
a	O
tumor	O
suppressor	I:C0079427
.	O

Among	O
upregulated	O
miRNAs	B:C1101610
in	O
ASCs	O
compared	O
with	O
fibroblasts	O
,	O
we	O
focused	O
on	O
miR	O
-145	I:C1537799
,	O
which	O
was	O
known	O
as	O
a	O
tumor	O
suppressor	I:C0079427
.	O

Among	O
upregulated	O
miRNAs	O
in	O
ASCs	B:C0162597
compared	O
with	O
fibroblasts	O
,	O
we	O
focused	O
on	O
miR	O
-145	I:C1537799
,	O
which	O
was	O
known	O
as	O
a	O
tumor	O
suppressor	I:C0079427
.	O

Among	O
upregulated	O
miRNAs	O
in	O
ASCs	O
compared	O
with	O
fibroblasts	B:C0016030
,	O
we	O
focused	O
on	O
miR	O
-145	I:C1537799
,	O
which	O
was	O
known	O
as	O
a	O
tumor	O
suppressor	I:C0079427
.	O

Among	O
upregulated	O
miRNAs	O
in	O
ASCs	O
compared	O
with	O
fibroblasts	O
,	O
we	O
focused	O
on	O
miR	B:C1537799
-145	I:C1537799
,	O
which	O
was	O
known	O
as	O
a	O
tumor	O
suppressor	I:C0079427
.	O

Among	O
upregulated	O
miRNAs	O
in	O
ASCs	O
compared	O
with	O
fibroblasts	O
,	O
we	O
focused	O
on	O
miR	O
-145	I:C1537799
,	O
which	O
was	O
known	O
as	O
a	O
tumor	B:C0079427
suppressor	I:C0079427
.	O

Adipose	B:C0162597
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
-	O
derived	O
conditioned	O
medium	I:C0162518
(	I:C0162518
CM	I:C0162518
)	I:C0162518
significantly	O
inhibited	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cell	O
proliferation	I:C0596290
,	O
inducing	O
apoptosis	O
,	O
but	O
the	O
effect	O
was	O
canceled	O
by	O
miR-145	O
knockdown	O
in	O
ASCs	O
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
-	O
derived	O
conditioned	B:C0162518
medium	I:C0162518
(	I:C0162518
CM	I:C0162518
)	I:C0162518
significantly	O
inhibited	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cell	O
proliferation	I:C0596290
,	O
inducing	O
apoptosis	O
,	O
but	O
the	O
effect	O
was	O
canceled	O
by	O
miR-145	O
knockdown	O
in	O
ASCs	O
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
-	O
derived	O
conditioned	O
medium	I:C0162518
(	I:C0162518
CM	I:C0162518
)	I:C0162518
significantly	O
inhibited	O
PC3M	B:C0682523
-	I:C0682523
luc2	I:C0682523
cell	O
proliferation	I:C0596290
,	O
inducing	O
apoptosis	O
,	O
but	O
the	O
effect	O
was	O
canceled	O
by	O
miR-145	O
knockdown	O
in	O
ASCs	O
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
-	O
derived	O
conditioned	O
medium	I:C0162518
(	I:C0162518
CM	I:C0162518
)	I:C0162518
significantly	O
inhibited	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cell	B:C0596290
proliferation	I:C0596290
,	O
inducing	O
apoptosis	O
,	O
but	O
the	O
effect	O
was	O
canceled	O
by	O
miR-145	O
knockdown	O
in	O
ASCs	O
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
-	O
derived	O
conditioned	O
medium	I:C0162518
(	I:C0162518
CM	I:C0162518
)	I:C0162518
significantly	O
inhibited	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cell	O
proliferation	I:C0596290
,	O
inducing	O
apoptosis	B:C0162638
,	O
but	O
the	O
effect	O
was	O
canceled	O
by	O
miR-145	O
knockdown	O
in	O
ASCs	O
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
-	O
derived	O
conditioned	O
medium	I:C0162518
(	I:C0162518
CM	I:C0162518
)	I:C0162518
significantly	O
inhibited	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cell	O
proliferation	I:C0596290
,	O
inducing	O
apoptosis	O
,	O
but	O
the	O
effect	O
was	O
canceled	O
by	O
miR-145	B:C1537799
knockdown	O
in	O
ASCs	O
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
-	O
derived	O
conditioned	O
medium	I:C0162518
(	I:C0162518
CM	I:C0162518
)	I:C0162518
significantly	O
inhibited	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cell	O
proliferation	I:C0596290
,	O
inducing	O
apoptosis	O
,	O
but	O
the	O
effect	O
was	O
canceled	O
by	O
miR-145	O
knockdown	B:C2350567
in	O
ASCs	O
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
-	O
derived	O
conditioned	O
medium	I:C0162518
(	I:C0162518
CM	I:C0162518
)	I:C0162518
significantly	O
inhibited	O
PC3M	O
-	I:C0682523
luc2	I:C0682523
cell	O
proliferation	I:C0596290
,	O
inducing	O
apoptosis	O
,	O
but	O
the	O
effect	O
was	O
canceled	O
by	O
miR-145	O
knockdown	O
in	O
ASCs	B:C0162597
.	O

Adipose	B:C0162597
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
miR-145	O
knockdown	O
conditioned	O
medium	I:C0162518
also	O
reduced	O
the	O
expression	O
of	O
Caspase	O
3	I:C0291573
/	O
7	O
with	O
increased	O
antiapoptotic	O
protein	O
,	O
BclxL	O
,	O
expression	O
in	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
miR-145	B:C1537799
knockdown	O
conditioned	O
medium	I:C0162518
also	O
reduced	O
the	O
expression	O
of	O
Caspase	O
3	I:C0291573
/	O
7	O
with	O
increased	O
antiapoptotic	O
protein	O
,	O
BclxL	O
,	O
expression	O
in	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
miR-145	O
knockdown	B:C2350567
conditioned	O
medium	I:C0162518
also	O
reduced	O
the	O
expression	O
of	O
Caspase	O
3	I:C0291573
/	O
7	O
with	O
increased	O
antiapoptotic	O
protein	O
,	O
BclxL	O
,	O
expression	O
in	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
miR-145	O
knockdown	O
conditioned	B:C0162518
medium	I:C0162518
also	O
reduced	O
the	O
expression	O
of	O
Caspase	O
3	I:C0291573
/	O
7	O
with	O
increased	O
antiapoptotic	O
protein	O
,	O
BclxL	O
,	O
expression	O
in	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
miR-145	O
knockdown	O
conditioned	O
medium	I:C0162518
also	O
reduced	O
the	O
expression	B:C1171362
of	O
Caspase	O
3	I:C0291573
/	O
7	O
with	O
increased	O
antiapoptotic	O
protein	O
,	O
BclxL	O
,	O
expression	O
in	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
miR-145	O
knockdown	O
conditioned	O
medium	I:C0162518
also	O
reduced	O
the	O
expression	O
of	O
Caspase	B:C0291573
3	I:C0291573
/	O
7	O
with	O
increased	O
antiapoptotic	O
protein	O
,	O
BclxL	O
,	O
expression	O
in	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
miR-145	O
knockdown	O
conditioned	O
medium	I:C0162518
also	O
reduced	O
the	O
expression	O
of	O
Caspase	O
3	I:C0291573
/	O
7	B:C0537969
with	O
increased	O
antiapoptotic	O
protein	O
,	O
BclxL	O
,	O
expression	O
in	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
miR-145	O
knockdown	O
conditioned	O
medium	I:C0162518
also	O
reduced	O
the	O
expression	O
of	O
Caspase	O
3	I:C0291573
/	O
7	O
with	O
increased	O
antiapoptotic	B:C2986514
protein	O
,	O
BclxL	O
,	O
expression	O
in	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
miR-145	O
knockdown	O
conditioned	O
medium	I:C0162518
also	O
reduced	O
the	O
expression	O
of	O
Caspase	O
3	I:C0291573
/	O
7	O
with	O
increased	O
antiapoptotic	O
protein	B:C0033684
,	O
BclxL	O
,	O
expression	O
in	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
miR-145	O
knockdown	O
conditioned	O
medium	I:C0162518
also	O
reduced	O
the	O
expression	O
of	O
Caspase	O
3	I:C0291573
/	O
7	O
with	O
increased	O
antiapoptotic	O
protein	O
,	O
BclxL	B:C0219472
,	O
expression	O
in	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
miR-145	O
knockdown	O
conditioned	O
medium	I:C0162518
also	O
reduced	O
the	O
expression	O
of	O
Caspase	O
3	I:C0291573
/	O
7	O
with	O
increased	O
antiapoptotic	O
protein	O
,	O
BclxL	O
,	O
expression	B:C1171362
in	O
PC3	O
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
.	O

Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
miR-145	O
knockdown	O
conditioned	O
medium	I:C0162518
also	O
reduced	O
the	O
expression	O
of	O
Caspase	O
3	I:C0291573
/	O
7	O
with	O
increased	O
antiapoptotic	O
protein	O
,	O
BclxL	O
,	O
expression	O
in	O
PC3	B:C0682523
M	I:C0682523
-	I:C0682523
luc2	I:C0682523
cells	I:C0682523
.	O

This	O
study	B:C2603343
provides	O
preclinical	O
data	O
that	O
ASCs	O
inhibit	O
prostate	O
cancer	I:C0936223
growth	O
,	O
inducing	O
prostate	O
cancer	I:C0936223
cell	O
apoptosis	O
with	O
reduced	O
activity	O
of	O
BclxL	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
miR	O
-145	I:C1537799
,	O
including	O
exosomes	O
released	O
from	O
ASCs	O
,	O
suggesting	O
that	O
Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
administration	O
could	O
be	O
a	O
novel	O
and	O
promising	O
therapeutic	O
strategy	O
in	O
patients	O
with	O
prostate	O
cancer	I:C0936223
.	O

This	O
study	O
provides	O
preclinical	O
data	O
that	O
ASCs	B:C0162597
inhibit	O
prostate	O
cancer	I:C0936223
growth	O
,	O
inducing	O
prostate	O
cancer	I:C0936223
cell	O
apoptosis	O
with	O
reduced	O
activity	O
of	O
BclxL	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
miR	O
-145	I:C1537799
,	O
including	O
exosomes	O
released	O
from	O
ASCs	O
,	O
suggesting	O
that	O
Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
administration	O
could	O
be	O
a	O
novel	O
and	O
promising	O
therapeutic	O
strategy	O
in	O
patients	O
with	O
prostate	O
cancer	I:C0936223
.	O

This	O
study	O
provides	O
preclinical	O
data	O
that	O
ASCs	O
inhibit	O
prostate	B:C0936223
cancer	I:C0936223
growth	O
,	O
inducing	O
prostate	O
cancer	I:C0936223
cell	O
apoptosis	O
with	O
reduced	O
activity	O
of	O
BclxL	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
miR	O
-145	I:C1537799
,	O
including	O
exosomes	O
released	O
from	O
ASCs	O
,	O
suggesting	O
that	O
Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
administration	O
could	O
be	O
a	O
novel	O
and	O
promising	O
therapeutic	O
strategy	O
in	O
patients	O
with	O
prostate	O
cancer	I:C0936223
.	O

This	O
study	O
provides	O
preclinical	O
data	O
that	O
ASCs	O
inhibit	O
prostate	O
cancer	I:C0936223
growth	B:C1516170
,	O
inducing	O
prostate	O
cancer	I:C0936223
cell	O
apoptosis	O
with	O
reduced	O
activity	O
of	O
BclxL	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
miR	O
-145	I:C1537799
,	O
including	O
exosomes	O
released	O
from	O
ASCs	O
,	O
suggesting	O
that	O
Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
administration	O
could	O
be	O
a	O
novel	O
and	O
promising	O
therapeutic	O
strategy	O
in	O
patients	O
with	O
prostate	O
cancer	I:C0936223
.	O

This	O
study	O
provides	O
preclinical	O
data	O
that	O
ASCs	O
inhibit	O
prostate	O
cancer	I:C0936223
growth	O
,	O
inducing	O
prostate	B:C0936223
cancer	I:C0936223
cell	O
apoptosis	O
with	O
reduced	O
activity	O
of	O
BclxL	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
miR	O
-145	I:C1537799
,	O
including	O
exosomes	O
released	O
from	O
ASCs	O
,	O
suggesting	O
that	O
Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
administration	O
could	O
be	O
a	O
novel	O
and	O
promising	O
therapeutic	O
strategy	O
in	O
patients	O
with	O
prostate	O
cancer	I:C0936223
.	O

This	O
study	O
provides	O
preclinical	O
data	O
that	O
ASCs	O
inhibit	O
prostate	O
cancer	I:C0936223
growth	O
,	O
inducing	O
prostate	O
cancer	I:C0936223
cell	B:C0007634
apoptosis	O
with	O
reduced	O
activity	O
of	O
BclxL	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
miR	O
-145	I:C1537799
,	O
including	O
exosomes	O
released	O
from	O
ASCs	O
,	O
suggesting	O
that	O
Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
administration	O
could	O
be	O
a	O
novel	O
and	O
promising	O
therapeutic	O
strategy	O
in	O
patients	O
with	O
prostate	O
cancer	I:C0936223
.	O

This	O
study	O
provides	O
preclinical	O
data	O
that	O
ASCs	O
inhibit	O
prostate	O
cancer	I:C0936223
growth	O
,	O
inducing	O
prostate	O
cancer	I:C0936223
cell	O
apoptosis	B:C0162638
with	O
reduced	O
activity	O
of	O
BclxL	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
miR	O
-145	I:C1537799
,	O
including	O
exosomes	O
released	O
from	O
ASCs	O
,	O
suggesting	O
that	O
Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
administration	O
could	O
be	O
a	O
novel	O
and	O
promising	O
therapeutic	O
strategy	O
in	O
patients	O
with	O
prostate	O
cancer	I:C0936223
.	O

This	O
study	O
provides	O
preclinical	O
data	O
that	O
ASCs	O
inhibit	O
prostate	O
cancer	I:C0936223
growth	O
,	O
inducing	O
prostate	O
cancer	I:C0936223
cell	O
apoptosis	O
with	O
reduced	O
activity	O
of	O
BclxL	B:C0219472
,	O
at	O
least	O
in	O
part	O
,	O
by	O
miR	O
-145	I:C1537799
,	O
including	O
exosomes	O
released	O
from	O
ASCs	O
,	O
suggesting	O
that	O
Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
administration	O
could	O
be	O
a	O
novel	O
and	O
promising	O
therapeutic	O
strategy	O
in	O
patients	O
with	O
prostate	O
cancer	I:C0936223
.	O

This	O
study	O
provides	O
preclinical	O
data	O
that	O
ASCs	O
inhibit	O
prostate	O
cancer	I:C0936223
growth	O
,	O
inducing	O
prostate	O
cancer	I:C0936223
cell	O
apoptosis	O
with	O
reduced	O
activity	O
of	O
BclxL	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
miR	B:C1537799
-145	I:C1537799
,	O
including	O
exosomes	O
released	O
from	O
ASCs	O
,	O
suggesting	O
that	O
Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
administration	O
could	O
be	O
a	O
novel	O
and	O
promising	O
therapeutic	O
strategy	O
in	O
patients	O
with	O
prostate	O
cancer	I:C0936223
.	O

This	O
study	O
provides	O
preclinical	O
data	O
that	O
ASCs	O
inhibit	O
prostate	O
cancer	I:C0936223
growth	O
,	O
inducing	O
prostate	O
cancer	I:C0936223
cell	O
apoptosis	O
with	O
reduced	O
activity	O
of	O
BclxL	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
miR	O
-145	I:C1537799
,	O
including	O
exosomes	B:C2350332
released	O
from	O
ASCs	O
,	O
suggesting	O
that	O
Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
administration	O
could	O
be	O
a	O
novel	O
and	O
promising	O
therapeutic	O
strategy	O
in	O
patients	O
with	O
prostate	O
cancer	I:C0936223
.	O

This	O
study	O
provides	O
preclinical	O
data	O
that	O
ASCs	O
inhibit	O
prostate	O
cancer	I:C0936223
growth	O
,	O
inducing	O
prostate	O
cancer	I:C0936223
cell	O
apoptosis	O
with	O
reduced	O
activity	O
of	O
BclxL	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
miR	O
-145	I:C1537799
,	O
including	O
exosomes	O
released	O
from	O
ASCs	B:C0162597
,	O
suggesting	O
that	O
Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
administration	O
could	O
be	O
a	O
novel	O
and	O
promising	O
therapeutic	O
strategy	O
in	O
patients	O
with	O
prostate	O
cancer	I:C0936223
.	O

This	O
study	O
provides	O
preclinical	O
data	O
that	O
ASCs	O
inhibit	O
prostate	O
cancer	I:C0936223
growth	O
,	O
inducing	O
prostate	O
cancer	I:C0936223
cell	O
apoptosis	O
with	O
reduced	O
activity	O
of	O
BclxL	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
miR	O
-145	I:C1537799
,	O
including	O
exosomes	O
released	O
from	O
ASCs	O
,	O
suggesting	O
that	O
Adipose	B:C0162597
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
administration	O
could	O
be	O
a	O
novel	O
and	O
promising	O
therapeutic	O
strategy	O
in	O
patients	O
with	O
prostate	O
cancer	I:C0936223
.	O

This	O
study	O
provides	O
preclinical	O
data	O
that	O
ASCs	O
inhibit	O
prostate	O
cancer	I:C0936223
growth	O
,	O
inducing	O
prostate	O
cancer	I:C0936223
cell	O
apoptosis	O
with	O
reduced	O
activity	O
of	O
BclxL	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
miR	O
-145	I:C1537799
,	O
including	O
exosomes	O
released	O
from	O
ASCs	O
,	O
suggesting	O
that	O
Adipose	O
-	I:C0162597
derived	I:C0162597
stromal	I:C0162597
cell	I:C0162597
administration	O
could	O
be	O
a	O
novel	O
and	O
promising	O
therapeutic	O
strategy	O
in	O
patients	O
with	O
prostate	B:C0936223
cancer	I:C0936223
.	O

